Skip to content

Clinical trials

Completed Phase 3 Alzheimer Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 3 Status: Completed Clear all

161 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20019
20024
200312
20043
20056
20061
200713
20089
200910
20108
20115
20127
20136
20148
20154
20165
20175
20184
20193
20201
20217
20223
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed161

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.13
Otsuka Pharmaceutical Development & Commercialization, Inc.10
National Institute on Aging (NIA)8
Eli Lilly and Company7
Avid Radiopharmaceuticals6
GE Healthcare5
Novartis Pharmaceuticals5
H. Lundbeck A/S4
Pfizer4
Axsome Therapeutics, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease161
Dementia50
Cognitive Dysfunction22
Psychomotor Agitation17
Memory Disorders15
Brain Diseases9
Dementia, Vascular8
Neurodegenerative Diseases8
Mental Disorders7
Nervous System Diseases5

Trials

Showing 1 to 25 of 161. Each trial links to its page on Pharma Observatory.

61 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.